InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,418.04
(
-1.89%
)
US TECH 100
18,256.00
(
-3.11%
)
Dow Jones
40,142.12
(
-1.72%
)
Brent Oil
79.69
(
-2.24%
)
Bitcoin
62,938.11
(
-2.57%
)
Post# of 48316
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

hschlauch

Send PM Follow Ignore
Followers 19
Posts 334
Boards Moderated 0
Alias Born 07/25/2016

hschlauch

Re: Waitforit53 post# 39690

Thursday, 08/31/2017 11:35:46 AM

Thursday, August 31, 2017 11:35:46 AM

Post# of 48316
These data are for patients in a first line setting - no prior therapies. Oncosec is going for anti-PD-1 failures in a second/third line setting, ie patients who are progressing following anti-PD-1 treatment.

It is worth noting that that the Epac/Keytruda combo has relatively fewer complete responders compared to interim data presented earlier this year.





Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent ONCSQ News
More ONCSQ News
InvestorsHub NewsWire

FEATURED POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • Aug 1, 2024 9:28 AM

Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM

VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM

Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM

Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM

Kona Gold Beverage Significantly Reduces Debt from Multiple Holders • KGKG • Jul 31, 2024 9:00 AM

Start posting your company's news
Only $200 per official company press release!